Insider Transactions in Q1 2021 at Alkermes Plc. (ALKS)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 21
2021
|
Richard F Pops Director and CEO, Alkermes plc |
SELL
Payment of exercise price or tax liability
|
Direct |
14,386
-1.78%
|
$273,334
$19.58 P/Share
|
|
Feb 21
2021
|
Richard F Pops Director and CEO, Alkermes plc |
BUY
Exercise of conversion of derivative security
|
Direct |
32,400
+3.86%
|
-
|
|
Feb 21
2021
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,412
-2.84%
|
$26,828
$19.58 P/Share
|
|
Feb 21
2021
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,800
+8.8%
|
-
|
|
Feb 21
2021
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,022
-2.64%
|
$38,418
$19.58 P/Share
|
|
Feb 21
2021
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
6,875
+8.23%
|
-
|
|
Feb 21
2021
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,022
-6.53%
|
$38,418
$19.58 P/Share
|
|
Feb 21
2021
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,875
+18.18%
|
-
|
|
Feb 21
2021
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,412
-2.03%
|
$26,828
$19.58 P/Share
|
|
Feb 21
2021
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,800
+6.45%
|
-
|
|
Feb 21
2021
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,587
-1.18%
|
$49,153
$19.58 P/Share
|
|
Feb 20
2021
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,378
-2.97%
|
$26,182
$19.58 P/Share
|
|
Feb 20
2021
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,589
+9.01%
|
-
|
|
Feb 20
2021
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,061
-2.87%
|
$39,159
$19.58 P/Share
|
|
Feb 20
2021
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
7,036
+8.92%
|
-
|
|
Feb 20
2021
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,064
-11.29%
|
$58,216
$19.58 P/Share
|
|
Feb 20
2021
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,095
+27.12%
|
-
|
|
Feb 20
2021
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,374
-2.08%
|
$26,106
$19.58 P/Share
|
|
Feb 20
2021
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,589
+6.49%
|
-
|
|
Feb 20
2021
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
11,178
+2.5%
|
-
|
|
Feb 20
2021
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,360
-1.09%
|
$44,840
$19.58 P/Share
|
|
Feb 20
2021
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,292
-20.52%
|
$24,548
$19.58 P/Share
|
|
Feb 20
2021
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,824
+37.79%
|
-
|
|
Feb 17
2021
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
868
-2.04%
|
$16,492
$19.97 P/Share
|
|
Feb 17
2021
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+5.54%
|
-
|
|
Feb 17
2021
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
868
-1.32%
|
$16,492
$19.97 P/Share
|
|
Feb 17
2021
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+3.67%
|
-
|
|
Feb 17
2021
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
781
-1.25%
|
$14,839
$19.97 P/Share
|
|
Feb 17
2021
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+3.48%
|
-
|
|
Feb 17
2021
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,492
-0.7%
|
$28,348
$19.97 P/Share
|
|
Feb 17
2021
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+1.4%
|
-
|
|
Feb 17
2021
|
Richard F Pops Director and CEO, Alkermes plc |
SELL
Payment of exercise price or tax liability
|
Direct |
3,869
-0.5%
|
$73,511
$19.97 P/Share
|
|
Feb 17
2021
|
Richard F Pops Director and CEO, Alkermes plc |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+1.11%
|
-
|
|
Feb 16
2021
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
825
-2.01%
|
$15,675
$19.79 P/Share
|
|
Feb 16
2021
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,375
+5.48%
|
-
|
|
Feb 16
2021
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,172
-1.82%
|
$22,268
$19.79 P/Share
|
|
Feb 16
2021
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
3,375
+4.99%
|
-
|
|
Feb 16
2021
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,172
-6.44%
|
$22,268
$19.79 P/Share
|
|
Feb 16
2021
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,375
+15.64%
|
-
|
|
Feb 16
2021
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
825
-1.35%
|
$15,675
$19.79 P/Share
|
|
Feb 16
2021
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,375
+3.75%
|
-
|
|
Feb 16
2021
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,678
-0.8%
|
$31,882
$19.79 P/Share
|
|
Feb 16
2021
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
3,375
+1.58%
|
-
|
|
Feb 16
2021
|
Richard F Pops Director and CEO, Alkermes plc |
SELL
Payment of exercise price or tax liability
|
Direct |
8,074
-1.04%
|
$153,406
$19.79 P/Share
|
|
Feb 16
2021
|
Richard F Pops Director and CEO, Alkermes plc |
BUY
Exercise of conversion of derivative security
|
Direct |
18,125
+2.28%
|
-
|
|
Jan 13
2021
|
Wendy L Dixon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+41.4%
|
$420,000
$12.62 P/Share
|